Document is current
Any future updates will be listed below
-
Authors
Magoon, Matthew J.
Nazer, Babak
Akoum, Nazem
Boyle, Patrick M.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR002319, UL1 TR002319, UL1 TR002319)
National Heart, Lung, and Blood Institute (R01 HL158667, R01 HL158667)
John L. Locke Charitable Trust Fund
Catherine Holmes Wilkins Charitable Foundation
- License Information
-
More Information
Article History
Accepted: 6 September 2024
First Online: 20 September 2024
Declarations
:
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: Mr. Magoon has nothing to report. Dr. Nazer reports advisory board roles and consulting work for Biosense-Webster, advisory board roles, consulting work, and investigator-initiated Research for Siemens, and consulting for Edwards LifeSciences. Dr. Akoum reports grants from the National Institutes of Health and the John L. Locke Charitable Trust Fund, during the conduct of the study. Dr. Boyle reports grants from the National Institutes of Health, the UW Institute of Translational Health Science, and the Catherine Holmes Wilkins Charitable Foundation, during the conduct of the study; in addition, Dr. Boyle is listed on relevant US Patent Nos. 11,278,247, 10,842,401, and 10,687,898, all of which are assigned to the Johns Hopkins University.
